Series C - Innate Pharma - Sep 1, 2004 Funding Round Profile - Cointime

Bitcoin $98,892.63 +0.93%
Ethereum $3,339.98 +6.31%
BNB $625.20 +2.64%
Optimism $2.09 +23.94%
Arbitrum $0.78 +12.14%
Solana $258.89 +7.19%
Polygon $0.46 +6.09%
Cosmos $6.84 +11.55%
Avalanche $37.51 +10.47%

Bitcoin $98,892.63 +0.93%
Ethereum $3,339.98 +6.31%
BNB $625.20 +2.64%
Optimism $2.09 +23.94%
Arbitrum $0.78 +12.14%
Solana $258.89 +7.19%
Polygon $0.46 +6.09%
Cosmos $6.84 +11.55%
Avalanche $37.51 +10.47%

Innate Pharma

company

Funding Round

Series C

Money Raised

€ 15M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Novo Nordisk	-	-	-	Detail
Akka Venture	-	-	-	Detail
NIF SMBC Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jan 1, 2002	Series B	€ 20M	Akka Venture	Detail